# Chembio Current Asset

CEMI | Stock | ## USD 0.81 0.04 4.71% |

Chembio Diagnostics fundamentals help investors to digest information that contributes to Chembio Diagnostics' financial success or failures. It also enables traders to predict the movement of Chembio Stock. The fundamental analysis module provides a way to measure Chembio Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chembio Diagnostics stock.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Chembio | Current Asset |

**M**, while Net Current Assets as percentage of Total Assets are projected to decrease to 49.52.

## Chembio Current Asset Analysis

Chembio Diagnostics' Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets. 2019 | 2020 | 2021 | 2022 (projected) | |

Revenues USD | 34.46 M | 32.47 M | 47.82 M | 41.89 M |

Revenues | 34.46 M | 32.47 M | 47.82 M | 41.89 M |

Current Asset | = | Cash | + | Deposits | + | Liquid Assets |

## Current Chembio Diagnostics Current Asset | 12.63 M |

Most of Chembio Diagnostics' fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chembio Diagnostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

## Chembio Current Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for Chembio Diagnostics is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Current Asset. Since Chembio Diagnostics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Chembio Diagnostics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Chembio Diagnostics' interrelated accounts and indicators.

## Chembio Current Asset Historical Pattern

Today, most investors in Chembio Diagnostics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Chembio Diagnostics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Chembio Diagnostics current asset as a starting point in their analysis.

Chembio Diagnostics Current Asset |

Share

Timeline |

Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.

Compare to competition |

## Chembio Total Assets

## Total Assets | ## 58.3 Million |

In accordance with the recently published financial statements, Chembio Diagnostics has a Current Asset of 12.63

**M**. This is 99.41% lower than that of the Healthcare sector and 98.72% lower than that of the Diagnostics & Research industry. The current asset for all United States stocks is 99.86% higher than that of the company.## Chembio Current Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chembio Diagnostics' direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chembio Diagnostics could also be used in its relative valuation, which is a method of valuing Chembio Diagnostics by comparing valuation metrics of similar companies.Chembio Diagnostics is currently under evaluation in current asset category among related companies.

## Chembio Diagnostics Current Valuation Drivers

We derive many important indicators used in calculating different scores of Chembio Diagnostics from analyzing Chembio Diagnostics' financial statements. These drivers represent accounts that assess Chembio Diagnostics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Chembio Diagnostics' important valuation drivers and their relationship over time.

2017 | 2018 | 2019 | 2020 | 2021 | 2022 (projected) | ||

Net Income Per Employee | (38.62 K) | (26.66 K) | (42.21 K) | (71.69 K) | (100.6 K) | (103.25 K) | |

Revenue Per Employee | 145.55 K | 113.25 K | 106.37 K | 91.22 K | 141.9 K | 153.21 K | |

Average Assets | 19.09 M | 31.75 M | 50.08 M | 66.01 M | 66.07 M | 53.11 M | |

Earnings Before Interest Taxes and Depreciation Amortization EBITDA | (5.18 M) | (7.08 M) | (11.41 M) | (20.44 M) | (28.12 M) | (28.86 M) | |

Earnings Before Interest Taxes and Depreciation Amortization USD | (5.18 M) | (7.08 M) | (11.41 M) | (20.44 M) | (28.12 M) | (28.86 M) | |

Earnings before Tax | (6.46 M) | (7.93 M) | (14.18 M) | (25.98 M) | (33.97 M) | (34.86 M) | |

Average Equity | 15.2 M | 24.7 M | 27.21 M | 29.65 M | 30.14 M | 27.5 M | |

Enterprise Value | 99.24 M | 90.84 M | 83.16 M | 92.61 M | 24.17 M | 24.81 M | |

Free Cash Flow | (6.06 M) | (13.25 M) | (12.56 M) | (22.85 M) | (32.71 M) | (33.57 M) | |

Invested Capital | 6.56 M | 13.38 M | 46.81 M | 45.26 M | 52.03 M | 56.14 M | |

Invested Capital Average | 8.74 M | 10.77 M | 38.03 M | 45.9 M | 52.23 M | 56.36 M | |

Market Capitalization | 101.01 M | 97.28 M | 80.1 M | 95.84 M | 34.25 M | 53.56 M | |

Tangible Asset Value | 13.35 M | 32.04 M | 45.94 M | 55.28 M | 70.23 M | 75.77 M | |

Working Capital | 7.76 M | 21.93 M | 25.78 M | 27.39 M | 39.95 M | 43.1 M |

## Chembio Fundamentals

Return On Equity | (153.33) % | |||

Return On Asset | (26.23) % | |||

Profit Margin | (65.95) % | |||

Operating Margin | (43.58) % | |||

Current Valuation | 22.27 M | |||

Shares Outstanding | 30.05 M | |||

Shares Owned by Insiders | 1.31 % | |||

Shares Owned by Institutions | 9.34 % | |||

Number of Shares Shorted | 1.49 M | |||

Price to Earning | (8.49) X | |||

Price to Book | 0.54 X | |||

Price to Sales | 0.45 X | |||

Revenue | 57.91 M | |||

Gross Profit | 12.83 M | |||

EBITDA | (22.4 M) | |||

Net Income | (38.19 M) | |||

Cash and Equivalents | 24.4 M | |||

Cash per Share | 0.81 X | |||

Total Debt | 25.81 M | |||

Debt to Equity | 0.97 % | |||

Current Ratio | 3.54 X | |||

Book Value Per Share | 1.60 X | |||

Cash Flow from Operations | (27.99 M) | |||

Short Ratio | 17.07 X | |||

Earnings Per Share | (1.24) X | |||

Price to Earnings To Growth | (0.03) X | |||

Number of Employees | 337 | |||

Beta | 1.69 | |||

Market Capitalization | 25.84 M | |||

Total Asset | 20.82 M | |||

Retained Earnings | (73.47 M) | |||

Working Capital | 9.48 M | |||

Current Asset | 12.63 M | |||

Current Liabilities | 3.15 M | |||

Z Score | -4.9 |

## About Chembio Diagnostics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Chembio Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chembio Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chembio Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.Last Reported | Projected for 2022 | |

Current Assets | 55.2 M | 59.6 M |

Net Current Assets as percentage of Total Assets | 54.01 | 49.52 |

Average Assets | 66.1 M | 53.1 M |

Tangible Asset Value | 70.2 M | 75.8 M |

## Be your own money manager

Our tools can tell you how much better you can do entering a position in Chembio Diagnostics without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.## Did you try this?

### Run Portfolio Anywhere Now

## Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |

All Next | Launch Module |

## Pair Trading with Chembio Diagnostics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chembio Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chembio Diagnostics will appreciate offsetting losses from the drop in the long position's value.### Moving against Chembio Diagnostics

0.59 | GTH | Genetron Holdings | Earnings Call This Week | PairCorr | |||

0.51 | ACUR | Acura Pharma Cmn | Earnings Call Today | PairCorr |

The ability to find closely correlated positions to Chembio Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chembio Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chembio Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chembio Diagnostics to buy it.

The correlation of Chembio Diagnostics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chembio Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chembio Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Chembio Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Continue to Chembio Diagnostics Piotroski F Score and Chembio Diagnostics Altman Z Score analysis. Note that the Chembio Diagnostics information on this page should be used as a complementary analysis to other Chembio Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

## Complementary Tools for Chembio Stock analysis

When running Chembio Diagnostics price analysis, check to measure Chembio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chembio Diagnostics is operating at the current time. Most of Chembio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Chembio Diagnostics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chembio Diagnostics' price. Additionally, you may evaluate how the addition of Chembio Diagnostics to your portfolios can decrease your overall portfolio volatility.

Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | Go | |

Price TransformationUse Price Transformation models to analyze depth of different equity instruments across global markets | Go | |

My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | Go | |

Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | Go | |

Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation | Go | |

Technical AnalysisCheck basic technical indicators and analysis based on most latest market data | Go | |

Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios | Go | |

Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | Go | |

ETF DirectoryFind actively traded Exchange Traded Funds (ETF) from around the world | Go | |

Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios | Go | |

Risk-Return AnalysisView associations between returns expected from investment and the risk you assume | Go |

Is Chembio Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chembio Diagnostics. If investors know Chembio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chembio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Market Capitalization 26.3 M | Quarterly Revenue Growth YOY 0.42 | Return On Assets -0.3 | Return On Equity -2.06 |

The market value of Chembio Diagnostics is measured differently than its book value, which is the value of Chembio that is recorded on the company's balance sheet. Investors also form their own opinion of Chembio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Chembio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chembio Diagnostics' market value can be influenced by many factors that don't directly affect Chembio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Chembio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine Chembio Diagnostics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chembio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.